Roundup

Five things for pharma marketers to know: Thursday, August 18, 2022

Jack O'Brien

August 18, 2022

5:00 am

WHO renames two clades of monkeypox; Polio may have been spreading for more than a year; CDC lays out plan to be more nimble, accountable.

Five things for pharma marketers to know: Wednesday, August 17, 2022

Lecia Bushak

August 17, 2022

5:00 am

COVID public health emergency to be extended; Merck, Orna strike deal to develop mRNA vaccines; FDA gives priority review to new Lynparza indication.

Five things for pharma marketers to know: Tuesday, August 16, 2022

Lecia Bushak

August 16, 2022

5:00 am

Novavax to seek emergency authorization for new booster; Gilead breast cancer drug shows ‘clinically meaningful’ results; Brainstorm will submit ALS treatment for approval.

Five things for pharma marketers to know: Monday, August 15, 2022

Mackenzie Allen

August 15, 2022

5:00 am

CDC revisits COVID guidelines; Merck’s Januvia may contain traces of carcinogen; Novartis reports death of two children after gene therapy treatment.

Five things for pharma marketers to know: Friday, August 12, 2022

Mackenzie Allen

August 12, 2022

5:00 am

Monkeypox vax doses to be split among patients; Britain lacks booster shot plan; Langya virus infects 35 in China.

Five things for pharma marketers to know: Thursday, August 11, 2022

Mackenzie Allen

August 11, 2022

5:00 am

Court finds Walgreens liable for opioids in San Francisco; London children to be offered a polio booster; FDA will allow children to be vaccinated for monkeypox.

Five things for pharma marketers to know: Wednesday, August 10, 2022

Mackenzie Allen

August 10, 2022

5:00 am

Senate to vote again on insulin price cap; Texas challenges coverage for preventive care; FDA okays intradermal injection of monkeypox vax.

Five things for pharma marketers to know: Tuesday, August 9, 2022

Mackenzie Allen

August 9, 2022

5:00 am

BioNTech to deliver Omicron-adapted vaccine in October; Women self-managing abortions in Roe’s wake; GOP Senators block insulin cost cap.

Five things for pharma marketers to know: Monday, August 8, 2022

Mackenzie Allen

August 8, 2022

5:00 am

U.S. declares monkeypox a public health emergency; Spain reports hepatitis deaths in children; Polio found in New York wastewater samples.

Five things for pharma marketers to know: Friday, August 5, 2022

Mackenzie Allen

August 5, 2022

5:00 am

CDC to ease COVID restrictions for schools; Senate bill introduced to help people with disabilities access reproductive health care; monkeypox cases multiply in India.

Five things for pharma marketers to know: Thursday, August 4, 2022

Mackenzie Allen

August 4, 2022

5:00 am

COVID rebounds not limited to people treated with Paxlovid; Cases drop 9% globally; Medicare scraps plan to stop publishing some hospital safety data.

Five things for pharma marketers to know: Wednesday, August 3, 2022

Mackenzie Allen

August 3, 2022

5:00 am

Biden appoints monkeypox team; FDA to propose cut in nicotine levels; California declares public health state of emergency.

Five things for pharma marketers to know: Tuesday, August 2, 2022

Mackenzie Allen

August 2, 2022

5:00 am

Biden tests positive again; Former FDA leader characterizes monkeypox as a public health failure; Study: smokers 45% more likely to die from COVID.

Five things for pharma marketers to know: Monday, August 1, 2022

Mackenzie Allen

August 1, 2022

4:30 am

The Food and Drug Administration advises people under 50 to wait for new boosters; San Francisco and New York City sound alarm on monkeypox; U.S. reaches $1.74B deal with Moderna for updated COVID vaccine

Five things for pharma marketers to know: Friday, July 29, 2022

Mackenzie Allen

July 29, 2022

5:00 am

Researchers doubt effectiveness of vitamin D pills; Kansas will be the first state to vote on abortion; Cities to bring back mask mandates?